June 12, 2019
Seattle's InBios: First to Receive FDA Authorization for Zika Test
By info@inbios.com|2023-10-25T20:02:40+00:00June 27th, 2019|InBios In the News|
Seattle's InBios: First to Receive FDA Authorization for Zika Test
By info@inbios.com|2023-10-25T20:03:29+00:00May 29th, 2019|InBios In the News|
First Diagnostic Test for Zika Gets FDA's OK to Market
By info@inbios.com|2023-10-25T20:03:53+00:00May 28th, 2019|InBios In the News|
InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection
By info@inbios.com|2023-10-25T20:04:14+00:00May 23rd, 2019|InBios In the News|
FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios
By info@inbios.com|2023-10-25T20:05:30+00:00October 8th, 2018|InBios In the News|
InBios announces FDA clearance of its Dengue NS1 ELISA kit
By info@inbios.com|2023-10-25T20:09:50+00:00December 20th, 2016|InBios In the News|
InBios announces FDA emergency use authorization for its Zika ELISA
By info@inbios.com|2019-08-26T22:56:46+00:00May 15th, 2016|InBios In the News|
As Zika Virus Spreads, Gaps In Diagnostic Testing Present Opportunities For Drug Companies
By info@inbios.com|2019-08-26T22:56:46+00:00May 10th, 2016|InBios In the News|
UTMB researchers help discover simple, affordable diagnostic kit for chikungunya
By info@inbios.com|2019-08-26T22:56:46+00:00May 5th, 2016|InBios In the News|
Leishmania Rapid Diagnostic Device Receives FDA Clearance
By info@inbios.com|2023-10-25T20:10:51+00:00November 14th, 2014|InBios In the News|
FDA Clearance: CL Detect™ Rapid Test Read US Army Medical Research and Material Command Press Release...